| Sr. | Abstract Title |
| 1 | All-trans-retinoic acid-conjugated n-(2 hydroxypropyl) methacrylamide based micelles for effective delivery of doxorubicin in breast cancer |
| 2 | APPLICATION OF ARTIFICIAL INTELLIGENCE IN FORMULATION AND DEVELOPMENT OF SUSTAINED RELEASE FLOATING MICROSPHERES OF METOCLOPRAMIDE HCL |
| 3 | ASSESSING THE IN VITRO DRUG RELEASE IN SIMULATED SYNOVIAL FLUID AND CELLULAR INTERNALIZATION IN RAW 264.7 CELL LINE WITH DUAL DRUG (CHLOROQUINE PHOSPHATE & FLAVOPIRIDOL)-LOADED JANUS NANOSIZED EMULSIONS |
| 4 | BIODEGRADABLE HOLLOW MICROBALOONS OF POORLY WATER SOLUBLE DRUG: FORMULATION, IN-VITRO AND IN-VIVO CHARACTERIZATION |
| 5 | BIOGENIC SYNTHESIS OF SILVER NANOPARTICLES USING PHYLLOSTICTA CAPITALENSIS POSSESSING IN-VITRO ANTIMICROBIAL, ANTIOXIDANT AND ANTIDIABETIC ACTIVITY |
| 6 | BIOMIMETIC SYNTHESIS OF SILVER NANOPARTICLES USING ANNONA MURICATA, THEIR CHARACTERIZATION AND EVALUATION W.R.T. PROCESS VARIABLES |
| 7 | Cardiac Function Restoration by Co-Delivery of 5-Azacytidine in Protein Nanoparticles for Effective Stem Cell Differentiation in Rat Myocardial Infarction |
| 8 | CELLULAR UPTAKE, PHARMACOKINETICS AND BIODISTRIBUTION OF ISOMETAMIDIUM CHLORIDE LOADED LONG ACTING LIPID BASED NANOFORMULATION |
| 9 | CO-DELIVERY OF CHX/PDGF FROM LAYERED HYDROGEL SCAFFOLD FOR THE REGULATION OF DIABETIC WOUND MICROENVIRONMENT |
| 10 | Combinatorial Solid Lipid Nanoparticles loaded with Atorvastatin and Vinpocetine for the treatment of Cancer. |
| 11 | CURCUMIN LOADED TURMERIC OIL MICROEMULSION UNVEILED IMPROVED BRAIN PHARMACOKINETICS IN ADULT ZEBRAFISH |
| 12 | CYCLOSPORINE DELIVERY FROM GRAPHENE OXIDE LADEN CONTACT LENS FOR MANAGEMENT OF DRY EYE SYNDROME: IN VITRO AND IN VIVO STUDIES |
| 13 | DESIGN AND DEVELOPMENT OF RESVERATROL LOADED NANOSTRUCTURED LIPID CARRIER |
| 14 | DESIGN, DEVELOPMENT AND EVALUATION OF MANNOSYLATED NANOSTRUCTURED LIPID CARRIERS FOR SAFE AND EFFECTIVE LUNG TARGETED DELIVERY OF CLOFAZIMINE |
| 15 | DESIGNING & OPTIMIZATION OF BIOPOLYMERS BASED NANOSYSTEM: POTENTIAL CARRIER FOR CONTROLLED & SITE SPECIFIC DRUG DELIVERY. |
| 16 | DEVELOPMENT AND CHARACTERIZATION OF MICROEMULSION BASED HYDROGEL FOR TOPICAL DELIVERY |
| 17 | Development and characterization of reverse micelles for ocular delivery of hydrophillic drug |
| 18 | DEVELOPMENT AND EVALUATION OF BILAYER TABLET OF SOLID DISPERSION OF ARTEMETHER AND LUMEFANTRINE |
| 19 | Development and Evaluation of Liquid filled capsules of combination drugs for Malaria |
| 20 | Development and Evaluation of Lyophilized Palbociclib Nanosuspension by QbD approach |
| 21 | DEVELOPMENT AND EVALUATION OF QUERCETIN LOADED SOLID LIPID NANOPARTICLES AS AN ANTI-RHEUMATIC DRUG |
| 22 | DEVELOPMENT OF BRAIN TARGETED NLC LOADED IN-SITU GEL OF ZOLMITRIPTAN |
| 23 | DEVELOPMENT OF FULVESTRANT LOADED NANOEMULSION FOR MANAGEMENT OF BREAST CANCER |
| 24 | DEVELOPMENT OF MICRONEEDLE PATCH FOR TRANS-SCLERAL ADMINISTRATION OF TRIAMCINOLONE ACETONIDE TO ENHANCE VITREAL CONCENTRATION |
| 25 | DEVELOPMENT OF SELF-DOUBLE EMULSIFYING COMPOSITION FOR REPURPOSING OF DRUGS IN CANCER TREATMENT |
| 26 | DEVELOPMENT OF SUSTAINED-RELEASE MICRO BEADS FOR THE DELIVERY OF AN IMMUNOSUPPRESSANT DRUG INTENDED FOR THE MANAGEMENT OF SEVERE AUTOIMMUNE CONDITIONS FOR ORGAN TRANSPLANT RECIPIENTS |
| 27 | Dual drug (cyclosporin a & etodolac)-loaded oil-and/or polymer-based nano-dispersions: comparative in vitro drug release studies |
| 28 | EFFECT OF GRANULATING SOLVENTS ON GALENICAL PROPERTIES OF DIFFERENT POLYMORPHS OF D(-) MANNITOL |
| 29 | EFFECT OF PROCESS PARAMETERS ON GREEN SYNTHESIS OF SILVER NANOPARTICLES USING MORINGA OLEIFERA |
| 30 | EFFECT OF PROCESS VARIABLES ON COLLETOTRICHUM SIAMENSE MEDIATED SYNTHESIS OF SILVER NANOPARTICLES AND THEIR BIOLOGICAL EVALUATION |
| 31 | ENHANCED CELLULAR UPTAKE AND ORAL BIOAVAILABILITY OF LOPINAVIR PHOSPHOLIPID COMPLEX |
| 32 | ENHANCED DISSOLUTION RATE AND CELLULAR UPTAKE OF ALBENDAZOLE VIA PHOSPHOLIPID COMPLEX |
| 33 | EVALUATION AND COMPARISON OF IN-VITRO DISSOLUTION PROFILES FOR IMMEDIATE RELEASE TABLET OF DABIGATRAN ETIXILATE MESYLATE COCRYSTALS AND MARKETED FORMULATION. |
| 34 | EXPLORATIVE STUDIES OF SYNERGISTIC CO-LOADING OF VINCRISTINE INTO LIPOSOMAL DOXORUBICIN AGAINST BREAST CANCER AND LUNG CANCER |
| 35 | FABRICATION OF LIPID NANOPARTICLES OF 5-FLUOROURACIL USING IONIC LIQUID |
| 36 | FAST DISSOLVING MICRONEEDLE PATCH OF PAROXATINE HYDROCHLORIDE |
| 37 | FEASIBILITY OF EXTRUDING, PRINTING AND ENTERIC COATING OF A NON-ENTERIC 3D PRINTED HOLLOW CAPSULAR DEVICE USING EUDRAGIT® POLYMERS WITH DIVERSE DRUG RELEASE CHARACTERISTICS |
| 38 | FORMULATION AND CHARACTERIZATION OF PACLITAXEL NANOPARTICULATE DRUG DELIVERY SYSTEM FOR CANCER |
| 39 | FORMULATION AND DEVELOPMENT OF THYMOL LOADED GUM ACACIA AND CARBOPOL CROSSLINKED HYDROGEL WOUND DRESSINGS |
| 40 | FORMULATION AND EVALUATION OF CLOZAPINE BUCCAL PATCH AS NOVEL DRUG DELIVERY FOR ANTIPSYCHOTIC DRUG |
| 41 | FORMULATION AND EVALUATION OF GLUCOSAMINE FUNCTIONALIZED NIOSOMES CONTAINING RESVERATROL |
| 42 | FORMULATION AND EVALUATION OF HERBAL FAST DISSOLVING SUBLINGUAL FILM |
| 43 | FORMULATION AND EVALUATION OF IN SITU GELLING SYSTEM FOR NOSE TO BRAIN DRUG DELIVERY |
| 44 | FORMULATION AND EVALUATION OF RAFT FORMING DRUG DELIVERY SYSTEM OF FAMOTIDINE |
| 45 | FORMULATION AND EVALUATION OF SUMATRIPTAN SUCCINATE LOZENGES |
| 46 | FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED RELEASE FLOATING ALGINATE BEADS OF ALFUZOSIN HYDROCHLORIDE |
| 47 | FORMULATION DEVELOPMENT OF SUSTAINED RELEASE DRY POWDER INHALER OF ANTI-VIRAL DRUG FOR PULMONARY DRUG DELIVERY |
| 48 | FORMULATION OF FLOATING HYDROGEL EMBEDDED SELF GENERATING MICROBUBBLES FOR TREATMENT OF URINARY TRACT INFECTION |
| 49 | FORMULATION OF IN-SITU NASAL GEL CONTAINING RIZATRIPTAN NANO-STRUCTURED LIPID CARRIERS FOR THE MANAGEMENT OF MENTRUAL MIGRIANE. |
| 50 | FORMULATION, DEVELOPMENT AND CHARACTERIZATION OF SOLID-SMEDDS OF AGOMELATINE |
| 51 | FORMULATION, DEVELOPMENT AND CHARACTERIZATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF A MODEL DRUG |
| 52 | FUNCTIONALIZED POLYMERIC FILM FOR LOCALIZED DRUG DELIVERY TO TREAT GASTRIC CANCER |
| 53 | GELLAN GUM INCORPORATED CURCUMIN NANO-STRUCTURED CARRIER FOR WOUND HEALING. |
| 54 | HARNESSING CHITOSAN-VITAMIN E SUCCINATE CONJUGATED SUPRAMOLECULAR MICELLAR NANOAGGREGATE FOR EFFECTIVE LOADING OF OXALIPLATIN AND IMPROVED THERAPEUTIC POTENTIAL IN BREAST CANCER. |
| 55 | HOLLOW VAGINAL RING LOADED WITH PROBIOTIC LACTOBACILLI FOR TREATMENT OF BACTERIAL VAGINOSIS |
| 56 | INTRANASAL MICROEMULSION OF A SELECTIVE SEROTONIN RECEPTOR AGONIST FOR EFFECTIVE BRAIN TARGETING |
| 57 | INVESTIGATION OF IMPACT OF LIPID HAVING DIFFERENT CARBON CHAIN LENGTH ON FABRICATION OF LIPID NANOCARRIER OF 5-FLUOROURACIL |
| 58 | IN-VITRO DISSOLUTION KINETIC STUDY OF DIPYRIDAMOLE COCRYSTAL MATRIX TABLETS. |
| 59 | Lipid Coated Mesoporous Silica Nanoparticle Mediated Brain Targeted Delivery of Berberine: Preparation, Characterization, In vitro and In vivo Evaluation |
| 60 | Lipophilic metformin salts: Development, characterization, and in vitro anti-cancer activity |
| 61 | Lutein loaded solid lipid nanoparticles for ocular delivery: Statistical optimization and ex vivo evaluation |
| 62 | MECHANISTIC UNDERSTANDING OF LIPOSOME-BACTERIAL CELL FUSION PROCESS |
| 63 | MESOPOROUS SILICA NANOPARTICLE: AN EMERGING NANOMATERIAL FOR THE TREATMENT OF ATOPIC DERMATITIS |
| 64 | MITOCHONDRIA TARGETED LIPOSOMES OF METFORMIN FOR IMPROVED ANTICANCER ACTIVITY PREPARATION AND EVALUATION |
| 65 | MUCUNA PRURIENS SOLID LIQUID NANOPARTICLES: PREPARATION OPTIMIZATION AND BIOLOGICAL ACTIVITY |
| 66 | NOVEL FORMULATION OF RECOMBINANT HUMAN ERYTHROPOIETIN (rHuEPO) NANOPARTICLES USING A LIGAND AND BIODEGRADABLE POLYMER |
| 67 | NOVEL SPRAY DRIED SOLID DISPERSION COMPOSITION OF POORLY SOLUBLE POSACONAZOLE |
| 68 | NOVEL THERANOSTIC NANOPARTICLE FOR STABILIZATION OF ATHEROSCLEROTIC PLAQUE |
| 69 | OLEANOLIC ACID CONJUGATED HUMAN SERUM ALBUMIN- A NANOCARRIER FOR EFFECTIVE DELIVERY OF DOXORUBICIN AND COMBINATION THERAPEUTIC EFFECT IN ORAL CANCER |
| 70 | OXALIPLATIN-CONJUGATED STIMULI-SENSITIVE ALBUMIN NANOPARTICLES FOR THE TREATMENT OF BREST ADENO-CARCINOMA |
| 71 | Phyto-phospholipid complexation of Genistein for the improved bioactivity |
| 72 | Polymeric nanoparticles: A strategy to improve the bioavailability of antihypertensive drug combination |
| 73 | POROUS POLYMERIC FLAVONOIDAL VESICLES: DESIGN AND EVALUATION |
| 74 | PRELIMINARY INVESTIGATIONS INTO DEVELOPMENT OF LIPIDIC NANOFORMULATION CONTAINING ANTI-VEGF AGENT FOR TREATMENT OF ORAL CANCER |
| 75 | Preparation of Metallic Nanoparticles for wound healing. |
| 76 | PROTECTIVE EFFECT OF A NATURAL COUMARIN [AESCULETIN] ON ADJUVANT INDUCED RATS BY REGULATION RA FACTOR AND CRP LEVEL |
| 77 | QUALITY BY DESIGN (QbD) APPROACH FOR PREPARATION AND CHARACTERIZATION OF C-PHYCOCYANIN LOADED SURFACE MODIFIED CHITOSAN NANOPARTICLES FOR ANTITUMOR ACTIVITY. |
| 78 | QUERCETIN AND PIPERINE ENCAPSULATED NANOSTRUCTURED LIPID CARRIERS TO ATTENUATE ORAL CANCER: DEVELOPMENT, CHARACTERIZATION AND IN-VITRO CELLULAR EVALUATION |
| 79 | Quercetin loaded microsponges for topical sunscreen lotion |
| 80 | SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM OF HESPERIDIN LOADED TOPICAL GEL FOR TREATMENT OF INFLAMMATION |
| 81 | SOLUBILITY ENHANCEMENT OF POORLY SOLUBLE TOLVAPTAN WITH POLYVINYL ALCOHOL USING HOT MELT EXTRUSION TECHNOLOGY |
| 82 | Spray Dried Mucoadhesive Microspheres of Tapentadol Hydrochloride: Development, Characterization, and Evaluation |
| 83 | STABILITY STUDIES OF COCRYSTALS OF MEFLOQUINE HYDROCHLORIDE |
| 84 | STAT3 siRNA AND OXALIPLATIN COMBINATION DELIVERED USING NANOCOMPOSITE LAYER-BY-LAYER FILMS TO TREAT COLORECTAL CANCER |
| 85 | Sustained Release Multi-Particulates Formulation of Stereo-Selective Molecule of Ketoprofen by Wurster Coating Technique |
| 86 | SYSTEMATIC OPTIMIZATION OF-AND IN VITRO DRUG RELEASE PERFORMANCE FROM-CINNARIZINE LOADED OIL-LESS NANOSIZED EMULSIONS FOR TOPICAL OTIC APPLICATION |
| 87 | THE EVALUATION OF PHYSICAL STABILITY AND DEGRADATION KINETICS STUDY BY MULTI FACTORIAL TOOL FOR ANTI-TUBERCULOSIS DRUG-RIFABUTIN |
| 88 | Transdermal drug delivery of antipsychotic drug using nanostructured lipid carriers for bioavailability enhancement. |